HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Hyuck Im Selected Research

orantinib (SU6668)

12/2017Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.
4/2016Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
8/2014Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Hyuck Im Research Topics

Disease

109Breast Neoplasms (Breast Cancer)
10/2022 - 05/2005
47Neoplasms (Cancer)
10/2022 - 01/2004
17Neoplasm Metastasis (Metastasis)
11/2021 - 08/2004
13Triple Negative Breast Neoplasms
01/2020 - 03/2009
12Pathologic Complete Response
10/2022 - 04/2015
11Neutropenia
01/2020 - 01/2004
7Disease Progression
01/2020 - 01/2012
6Esophageal Squamous Cell Carcinoma
01/2022 - 10/2005
4Diarrhea
01/2012 - 01/2004
3Residual Neoplasm
10/2022 - 01/2007
3Anemia
07/2021 - 01/2004
3Thrombocytopenia (Thrombopenia)
01/2019 - 11/2004
3Febrile Neutropenia
08/2017 - 01/2012
3Stomach Neoplasms (Stomach Cancer)
02/2008 - 12/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2005 - 11/2003
2Exanthema (Rash)
07/2021 - 07/2004
2Ductal Carcinoma
05/2020 - 04/2014
2Left Ventricular Dysfunction
01/2020 - 01/2012
2Cardiotoxicity
04/2019 - 04/2018
2Leukopenia
01/2019 - 08/2017
2Noninfiltrating Intraductal Carcinoma (DCIS)
06/2018 - 01/2007
2Hypertension (High Blood Pressure)
06/2018 - 09/2013
2Cardiovascular Diseases (Cardiovascular Disease)
06/2018 - 09/2013
2Carcinoma (Carcinomatosis)
01/2017 - 08/2004
2Inflammatory Breast Neoplasms
06/2016 - 01/2012
2Alopecia (Baldness)
10/2015 - 10/2014
2Lymphatic Metastasis
10/2015 - 03/2015
2Vomiting
09/2013 - 01/2007
2Nausea
09/2013 - 01/2007
2Esophageal Neoplasms (Esophageal Cancer)
10/2005 - 08/2004
2Colorectal Neoplasms (Colorectal Cancer)
07/2005 - 04/2005
2Hepatocellular Carcinoma (Hepatoma)
11/2004 - 03/2002

Drug/Important Bio-Agent (IBA)

23Trastuzumab (Herceptin)FDA Link
10/2022 - 01/2011
22Hormones (Hormone)IBA
10/2022 - 06/2011
19human ERBB2 proteinIBA
10/2022 - 01/2011
16Docetaxel (Taxotere)FDA Link
10/2022 - 01/2007
16pertuzumabIBA
10/2022 - 01/2012
14ErbB Receptors (EGF Receptor)IBA
10/2022 - 04/2011
13taxaneIBA
10/2022 - 03/2009
12Estrogen ReceptorsIBA
01/2021 - 08/2010
10AnthracyclinesIBA
10/2022 - 08/2005
10Capecitabine (Xeloda)FDA Link
01/2022 - 07/2005
10Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2003
10Biomarkers (Surrogate Marker)IBA
10/2021 - 09/2011
7Ado-Trastuzumab EmtansineIBA
10/2022 - 10/2015
7Progesterone Receptors (Progesterone Receptor)IBA
05/2020 - 10/2010
7Lapatinib (GW572016)FDA Link
12/2019 - 01/2011
7GemcitabineFDA Link
01/2019 - 01/2004
7Doxorubicin (Adriamycin)FDA LinkGeneric
08/2017 - 11/2004
6Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 05/2013
5Fulvestrant (Faslodex)FDA Link
01/2021 - 09/2013
5ParaffinIBA
01/2018 - 05/2005
5Fluorouracil (Carac)FDA LinkGeneric
04/2009 - 04/2005
4ribociclibIBA
03/2022 - 01/2018
4palbociclibIBA
01/2021 - 08/2017
4Indicators and Reagents (Reagents)IBA
01/2021 - 06/2016
4Biological ProductsIBA
01/2020 - 02/2015
4Phenobarbital (Luminal)FDA Link
04/2019 - 01/2012
4eribulinFDA Link
01/2019 - 04/2017
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2017 - 04/2009
4Epidermal Growth Factor (EGF)IBA
04/2016 - 12/2008
3Taxoids (Taxanes)IBA
10/2022 - 08/2005
3exemestane (Aromasin)FDA Link
07/2021 - 09/2013
3Letrozole (Femara)FDA LinkGeneric
01/2021 - 01/2018
3Vinorelbine (Navelbine)FDA LinkGeneric
12/2019 - 03/2016
3Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 01/2019
3Pharmaceutical PreparationsIBA
01/2019 - 01/2012
3orantinib (SU6668)IBA
12/2017 - 08/2014
3Angiogenesis InhibitorsIBA
12/2017 - 08/2014
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022 - 02/2016
2CytokinesIBA
10/2021 - 01/2020
2Aromatase InhibitorsIBA
01/2020 - 09/2013
2TamoxifenFDA LinkGeneric
12/2019 - 11/2018
2Anastrozole (Arimidex)FDA LinkGeneric
11/2018 - 09/2013
2Formaldehyde (Formol)FDA Link
01/2018 - 01/2013
2Messenger RNA (mRNA)IBA
02/2016 - 01/2016
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2016 - 09/2013
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2016 - 04/2015
2PlatinumIBA
12/2013 - 03/2009
2Matrix Metalloproteinases (MMPs)IBA
04/2011 - 12/2008
2Proto-Oncogene Protein c-ets-1IBA
12/2008 - 07/2005
2Mitomycin (Mitomycin-C)FDA LinkGeneric
08/2008 - 07/2005
2Irinotecan (Camptosar)FDA LinkGeneric
07/2005 - 04/2005
2Leucovorin (Folinic Acid)FDA Link
07/2005 - 04/2005
2Etoposide (VP 16)FDA LinkGeneric
12/2003 - 11/2003
1Carboplatin (JM8)FDA LinkGeneric
10/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1trastuzumab deruxtecanIBA
11/2021
1Ritonavir (Norvir)FDA Link
11/2021

Therapy/Procedure

41Therapeutics
03/2022 - 11/2003
31Drug Therapy (Chemotherapy)
10/2021 - 01/2004
26Neoadjuvant Therapy
10/2022 - 01/2007
12Adjuvant Chemotherapy
01/2022 - 10/2005
8Radiotherapy
06/2018 - 09/2012
6Combination Drug Therapy (Combination Chemotherapy)
11/2017 - 01/2004
4Segmental Mastectomy (Lumpectomy)
06/2018 - 03/2015
3Chemoradiotherapy
12/2005 - 12/2003
2Salvage Therapy
01/2022 - 12/2013
2Palliative Care (Palliative Therapy)
01/2019 - 01/2013
2Maintenance Chemotherapy
07/2015 - 05/2013